Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Wyeth-Ayerst accepts four novel CNS gene candidates from Millennium

July 19, 2000

Discovery and properties of new apoptosis inhibitor produced by Streptomyces

July 19, 2000

New label change granted for Wyeth-Ayerst's Effexor XR

July 19, 2000

Increasing KYNA blocks nicotine-induced excitation of dopamine neurons

July 19, 2000

Brain-selective nicotinic agonist RJR-1734 enhances ACh release

July 19, 2000

New antiemetics from Takeda prove effective in range of animal models

July 18, 2000

Potential new antimigraine agents with an indole structure reported by Lilly

July 18, 2000

Nicotinic acetylcholine receptor ligands under study at major French laboratory

July 18, 2000

Sch-58261, an adenosine A2A antagonist, exerts beneficial effects in rat models of HD and PD

July 18, 2000

NK1 antagonists alter behavior in rodent models of antidepressant activity

July 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...